[go: up one dir, main page]

DK1694658T3 - Fremgangsmåde til fremstilling af et produkt af typen thiazolo[3,4,5-de][4,1]benzothiazepin - Google Patents

Fremgangsmåde til fremstilling af et produkt af typen thiazolo[3,4,5-de][4,1]benzothiazepin

Info

Publication number
DK1694658T3
DK1694658T3 DK04805651T DK04805651T DK1694658T3 DK 1694658 T3 DK1694658 T3 DK 1694658T3 DK 04805651 T DK04805651 T DK 04805651T DK 04805651 T DK04805651 T DK 04805651T DK 1694658 T3 DK1694658 T3 DK 1694658T3
Authority
DK
Denmark
Prior art keywords
benzothiazepine
thiazolo
preparation
product
benzothiazepine product
Prior art date
Application number
DK04805651T
Other languages
English (en)
Inventor
Stephane Mutti
Michel Lavigne
Michel Cheve
Joel Malpart
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1694658T3 publication Critical patent/DK1694658T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK04805651T 2003-12-12 2004-12-07 Fremgangsmåde til fremstilling af et produkt af typen thiazolo[3,4,5-de][4,1]benzothiazepin DK1694658T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0314574A FR2863612B1 (fr) 2003-12-12 2003-12-12 PROCEDE DE FABRICATION DE PRODUIT DE TYPE THIAZOLO[3,4,5-de] [4,1]BENZOTHIAZEPINE
PCT/FR2004/003138 WO2005066146A1 (fr) 2003-12-12 2004-12-07 Procede de fabrication de produit de type thiazolo[3,4,5-de][4,1]benzothiazepine

Publications (1)

Publication Number Publication Date
DK1694658T3 true DK1694658T3 (da) 2009-06-15

Family

ID=34610602

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04805651T DK1694658T3 (da) 2003-12-12 2004-12-07 Fremgangsmåde til fremstilling af et produkt af typen thiazolo[3,4,5-de][4,1]benzothiazepin

Country Status (17)

Country Link
EP (1) EP1694658B1 (da)
JP (1) JP2007519621A (da)
AR (1) AR046872A1 (da)
AT (1) ATE423773T1 (da)
CY (1) CY1109046T1 (da)
DE (1) DE602004019678D1 (da)
DK (1) DK1694658T3 (da)
ES (1) ES2322857T3 (da)
FR (1) FR2863612B1 (da)
HR (1) HRP20090237T1 (da)
PL (1) PL1694658T3 (da)
PT (1) PT1694658E (da)
RS (1) RS50758B (da)
SI (1) SI1694658T1 (da)
TW (1) TW200530256A (da)
UY (1) UY28665A1 (da)
WO (1) WO2005066146A1 (da)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3810450B2 (ja) * 1993-09-24 2006-08-16 武田薬品工業株式会社 縮合環化合物とその用途
JPH08259447A (ja) * 1995-03-24 1996-10-08 Takeda Chem Ind Ltd コレシストキニン拮抗剤
FR2766487B1 (fr) * 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant

Also Published As

Publication number Publication date
ATE423773T1 (de) 2009-03-15
EP1694658A1 (fr) 2006-08-30
PL1694658T3 (pl) 2009-07-31
CY1109046T1 (el) 2014-07-02
FR2863612B1 (fr) 2006-03-03
WO2005066146A1 (fr) 2005-07-21
RS50758B (sr) 2010-08-31
SI1694658T1 (sl) 2009-08-31
HRP20090237T1 (hr) 2009-06-30
UY28665A1 (es) 2005-07-29
PT1694658E (pt) 2009-04-23
EP1694658B1 (fr) 2009-02-25
FR2863612A1 (fr) 2005-06-17
TW200530256A (en) 2005-09-16
DE602004019678D1 (de) 2009-04-09
ES2322857T3 (es) 2009-06-30
AR046872A1 (es) 2005-12-28
JP2007519621A (ja) 2007-07-19

Similar Documents

Publication Publication Date Title
DK1482780T3 (da) Fremgangsmåde til fremstilling af et mælkeprodukt
DK1527187T3 (da) Fremstilling af et fermenteringsprodukt
AU2002322966A1 (en) Process for manufacturing mems
DK1794291T3 (da) Fremgangsmåde til fremstilling af et dejbaseret produkt
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
NO20043586L (no) Fremgangsmate for fremstilling av organiske forbindelser
DK1667967T3 (da) Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
FI20021899A0 (fi) Menetelmä kuitutuotteen valmistamiseksi
FI20012098A0 (fi) Menetelmä perkarboksyylihapon valmistamiseksi
IS7153A (is) Aðferð til framleiðslu á 14-hýdroxýnormorfínon afleiðu
IL176472A (en) Process for the preparation of pyridine derivatives
DK1686950T3 (da) Fremgangsmåde til udformning af et dentalprodukt
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
AU2003296868A1 (en) A process for the preparation of free standing membranes
DK1838683T3 (da) Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater
FR2852012B1 (fr) Procede de preparation de derives o-acyles du glucose
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
NO20052471D0 (no) Fremgangsmate for fremstilling av 3-metyltiopropanal.
NO20053368D0 (no) Fremgangsmate for fremstilling av en farmasoytisk ren polymorf I av olanzapin.
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
NO20044332L (no) Forbedret fremgangsmate for fremstilling av nevirapine
DK1694658T3 (da) Fremgangsmåde til fremstilling af et produkt af typen thiazolo[3,4,5-de][4,1]benzothiazepin
DK1311494T3 (da) Kontinuerlig fremgangsmåde til fremstilling af chlorthiazolpesticider